Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Change in Cash (2018 - 2025)

Health Catalyst's Change in Cash history spans 8 years, with the latest figure at $10.5 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 113.36% year-over-year to $10.5 million; the TTM value through Dec 2025 reached -$198.8 million, down 238.68%, while the annual FY2025 figure was -$198.8 million, 238.68% down from the prior year.
  • Change in Cash reached $10.5 million in Q4 2025 per HCAT's latest filing, up from -$10.4 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $126.4 million in Q3 2024 to a low of -$291.3 million in Q2 2025.
  • Average Change in Cash over 5 years is -$2.1 million, with a median of $2.9 million recorded in 2022.
  • Peak YoY movement for Change in Cash: surged 901.84% in 2021, then crashed 55577.33% in 2025.
  • A 5-year view of Change in Cash shows it stood at -$82.5 million in 2021, then surged by 90.41% to -$7.9 million in 2022, then skyrocketed by 242.88% to $11.3 million in 2023, then plummeted by 795.99% to -$78.7 million in 2024, then skyrocketed by 113.36% to $10.5 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Change in Cash are $10.5 million (Q4 2025), -$10.4 million (Q3 2025), and -$291.3 million (Q2 2025).